Showing results (1-10 of 988) with videos related to

Sort By:
Pageof 99
The Tokai Journal of Experimental and Clinical Medicine|February 15, 2011
Combination therapy by trastuzumab with 5'-deoxy-5-fluorouridine and cyclophosphamide in patients with metastatic breast cancerYuki Saito, Yasuhiro Suzuki, Yutaka Tokuda
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 14, 2006
[Molecular-targeted agents in breast cancer]Yutaka Tokuda, Yuki Saito, Yasuhiro Suzuki
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 15, 2006
[Herceptin-based therapy for breast cancer]Yutaka Tokuda, Yuki Saito, Yasuhiro Suzuki
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 17, 2011
[Tykerb for breast cancer]Yasuhiro Suzuki, Yuki Saito, Takuho Okamura, et al.
Breast Cancer (Tokyo, Japan)|July 18, 2009
The role of trastuzumab in the management of HER2-positive metastatic breast cancer: an updated reviewYutaka Tokuda, Yasuhiro Suzuki, Yuki Saito, et al.
Japanese Journal of Clinical Oncology|November 19, 2003
Combination of trastuzumab and vinorelbine in metastatic breast cancerYasuhiro Suzuki, Yutaka Tokuda, Yuki Saito, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 22, 2002
[Breast cancer]Yutaka Tokuda, Yuki Saito, Yasuhiro Suzuki, et al.
The Tokai Journal of Experimental and Clinical Medicine|September 9, 2005
Clinicopathological correlation between expression of PTHrP receptor and various prognostic factors in breast cancer without axillary lymph node metastasisYasuhiro Suzuki, Yutaka Tokuda, Yuki Saito, et al.
Breast Cancer (Tokyo, Japan)|December 6, 2006
Two cases of ductal adenoma of the breastKen-ichi Okada, Yasuhiro Suzuki, Yuki Saito, et al.
Breast Cancer (Tokyo, Japan)|February 4, 2011
Alteration of immunohistochemical biomarkers between pre- and post-chemotherapy: hormone receptors, HER2 and Ki-67Nobue Kumaki, Shinobu Umemura, Xiaoyan Tang, et al.
Pageof 99